Stocks in news today - 11 Feb 2025

has been emerged as the Lowest Bidder (L1) from South Western Railway for Survey, design, supply, installation, testing and commissioning for KAVACH equipment and other associated works over 790 RKM of Hubballi & Mysuru Divisions of South Western Railway. s has received approval for the acquisition of Mahananda Spa and Resorts, a Wholly Owned Subsidiary of Mankind Pharma, and owning company of The Westin Resort & Spa, Himalayas a 141 room hotel at Rishikesh. The company is in the process of entering into definitive agreements with the parties. The acquisition is in line with the company’s expansion strategy to diversify the portfolio to include leisure properties spanning different geographies. The Board of Directors of the Company at its meeting held on February 10, 2025 has, inter-alia, considered and approved the same. (ABCL) has made an investment of Rs 100 crore on rights basis, in the equity shares of Aditya Birla Capital Digital (ABCDL). Pursuant to the aforesaid investments, there is no change in the percentage shareholding of ABCL and ABCDL continues to be wholly owned subsidiary of the company. has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% (21 mcg/spray), to market a generic equivalent of Atrovent Nasal Spray, 0.03%, of Boehringer Ingelheim Pharmaceuticals, Inc. The product will be manufactured at Lupin’s Pithampur facility in India. Note : Make sure to follow risk management and position sizing at all times